Edinburgh Research Explorer

Brian Walker

(Former employee or visitor)

  1. 11 beta HSD1-/- mice have enhanced angiogenic response and improved myodardial function following coronary artery ligation

    Small, G. R., Hadoke, P. W. F., Gray, G. A., Sharif, I., Mullins, J. J., Seckl, J. R. & Walker, B. R., Oct 2004, In : Hypertension. 44, 4, p. 587-587 1 p.

    Research output: Contribution to journalArticle

  2. 11 beta-Hydroxysteroid dehydrogenase inhibition improves cognitive function in healthy elderly men and type 2 diabetics

    Sandeep, T. C., Yau, J. L. W., MacLullich, A. M. J., Noble, J., Deary, I. J., Walker, B. R. & Seckl, J. R., 27 Apr 2004, In : Proceedings of the National Academy of Sciences (PNAS). 101, 17, p. 6734-6739 6 p.

    Research output: Contribution to journalArticle

  3. 11 beta-Hydroxysteroid dehydrogenase type 1 as a therapeutic target in metabolic syndrome and beyond

    Walker, B. R. & Seckl, J. R., 26 Mar 2006, In : Abstracts of Papers - American Chemical Society, National Meeting. 231, 1 p.

    Research output: Contribution to journalMeeting abstract

  4. 11 beta-Hydroxysteroid dehydrogenase type 1 is a predominant 11 beta-reductase in the intact perfused rat liver

    Jamieson, P. M., Walker, B. R., Chapman, K. E., Andrew, R., Rossiter, S. & Seckl, J. R., Jun 2000, In : Journal of Endocrinology. 165, 3, p. 685-692 8 p.

    Research output: Contribution to journalArticle

  5. 11 beta-hydroxysteroid dehydrogenase type 2 in mouse aorta - Localization and influence on response to glucocorticoids

    Christy, C., Hadoke, P. W. F., Paterson, J. M., Mullins, J. J., Seckl, J. R. & Walker, B. R., Oct 2003, In : Hypertension. 42, 4, p. 580-587 8 p.

    Research output: Contribution to journalArticle

  6. 11-Beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) inhibitors in type 2 diabetes mellitus and obesity

    Hughes, K. A., Webster, S. P. & Walker, B. R., Apr 2008, In : Expert opinion on investigational drugs. 17, 4, p. 481-96 16 p.

    Research output: Contribution to journalLiterature review

  7. 11β-HSD1 inhibitors for the treatment of type 2 diabetes and cardiovascular disease

    Anderson, A. & Walker, B. R., Sep 2013, In : Drugs. 73, 13, p. 1385-1393 9 p.

    Research output: Contribution to journalArticle

  8. 11β-HSD1 suppresses cardiac fibroblast CXCL2, CXCL5 and neutrophil recruitment to the heart post MI

    Mylonas, K. J., Turner, N. A., Bageghni, S. A., Kenyon, C. J., White, C. I., McGregor, K., Kimmitt, R. A., Sulston, R., Kelly, V., Walker, B. R., Porter, K. E., Chapman, K. E. & Gray, G. A., 1 Jun 2017, In : Journal of Endocrinology. 233, 3, p. 315-327 13 p.

    Research output: Contribution to journalArticle

  9. 11β-Hydroxysteroid Dehydrogenase Activity in the Brain Does Not Contribute to Systemic Interconversion of Cortisol and Cortisone in Healthy Men

    Kilgour, A. H. M., Semple, S., Marshall, I., Andrews, P., Andrew, R. & Walker, B. R., Feb 2015, In : Journal of Clinical Endocrinology & Metabolism. 100, 2, p. 483-489 7 p.

    Research output: Contribution to journalArticle

Previous 1 2 3 4 5 6 7 8 ...25 Next